Literature DB >> 2404692

Participation of C3 and its ligands in complement activation.

J E Volanakis1.   

Abstract

C3, the most abundant complement protein in blood, plays a central role in the activation sequence of the complement system as well as in host defense. Expression of the multiple functions of C3 requires its cleavage by highly specific enzymes termed C3 convertases. C3 in a conformationally altered form, C3H2O, resulting from the slow spontaneous hydrolysis of the internal thioester bond of native C3, initiates the assembly of a C3 convertase which continuously cleaves C3 in the blood at slow rates generating a constant supply of small amounts of C3b. When an activator of the alternative complement pathway is present, C3b becomes covalently attached to its surface via an ester or amide bond. Activator surface-bound C3b initiates the assembly of an "amplification" C3 convertase, C3bBb(P), which can efficiently activate C3 and generate additional convertase complexes on the surface of the activator. C3b generated by an amplification or classical pathway C3 convertase can also bind covalently to the noncatalytic subunit, C3b or C4b, respectively, resulting in the generation of a C5 convertase, an enzyme catalyzing the cleavage/activation of C5. In terms of participation in host defense, several fragments of C3, including C3a, C3b, iC3b, and C3dg, mediate a number of important functions such as increased vascular permeability, enhancement of phagocytosis, elimination of immune complexes, and perhaps also proliferative responses and/or differentiation of B cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404692     DOI: 10.1007/978-3-642-74977-3_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  10 in total

1.  Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.

Authors:  J S Lin; L L Yan; Y Ho; P A Rice
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 2.  The inflammatory response to cell death.

Authors:  Kenneth L Rock; Hajime Kono
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

3.  Complement activation is involved in biological responses to leukocyte adsorptive apheresis.

Authors:  Shoichi Nishise; Yuji Takeda; Hiroaki Takeda; Katsuyoshi Ishihama; Tadahisa Fukui; Sumio Kawata
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

4.  Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.

Authors:  S A Hulton; R A Risdon; M J Dillon
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

5.  Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B.

Authors:  S C Williams; J Hinshelwood; S J Perkins; R B Sim
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

6.  Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro.

Authors:  Axel Seher; Joachim Nickel; Thomas D Mueller; Susanne Kneitz; Susanne Gebhardt; Tobias Meyer ter Vehn; Guenther Schlunck; Walter Sebald
Journal:  Mol Vis       Date:  2011-01-08       Impact factor: 2.367

7.  Expression analysis of immune related genes identified from the coelomocytes of sea cucumber (Apostichopus japonicus) in response to LPS challenge.

Authors:  Ying Dong; Hongjuan Sun; Zunchun Zhou; Aifu Yang; Zhong Chen; Xiaoyan Guan; Shan Gao; Bai Wang; Bei Jiang; Jingwei Jiang
Journal:  Int J Mol Sci       Date:  2014-10-27       Impact factor: 5.923

8.  Freeze-dried plasma proteins are stable at room temperature for at least 1 year.

Authors:  Jaimie Dufresne; Trung Hoang; Juliet Ajambo; Angelique Florentinus-Mefailoski; Peter Bowden; John Marshall
Journal:  Clin Proteomics       Date:  2017-10-27       Impact factor: 3.988

9.  Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.

Authors:  Loveleena Bansal; Eva-Maria Nichols; Daniel P Howsmon; Jessica Neisen; Christina M Bessant; Fraser Cunningham; Sebastien Petit-Frere; Steve Ludbrook; Valeriu Damian
Journal:  Front Pharmacol       Date:  2022-04-19       Impact factor: 5.988

10.  RNA sequencing analysis to capture the transcriptome landscape during skin ulceration syndrome progression in sea cucumber Apostichopus japonicus.

Authors:  Aifu Yang; Zunchun Zhou; Yongjia Pan; Jingwei Jiang; Ying Dong; Xiaoyan Guan; Hongjuan Sun; Shan Gao; Zhong Chen
Journal:  BMC Genomics       Date:  2016-06-14       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.